BERKELEY, Calif., May 7, 2007 (PRIME NEWSWIRE) -- Executives from XOMA Ltd. (Nasdaq:XOMA), a therapeutic antibody discovery and product development company, will be presenting at four upcoming industry and financial meetings, discussing the company’s proprietary technologies, business strategy and clinical progress.